Stay updated on Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial

Sign up to get notified when there's something new on the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The record presents details of a terminated phase II study evaluating Optune TTFields with nivolumab and ipilimumab for melanoma with brain metastases, including its eligibility criteria, treatment plan, outcomes, and results.
    Difference
    49%
    Check dated 2026-11-08T14:48:25.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T15:53:43.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” across its content and links to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:51:43.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T22:13:33.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site revision as v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-11T22:18:45.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record and navigation with an access-denied screen. This indicates a restriction or system issue that prevents viewing the trial details.
    Difference
    18%
    Check dated 2026-09-20T20:04:04.000Z thumbnail image

Stay in the know with updates to Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page.